Trades on 2 secondary markets

Switch Therapeutics

Switch Therapeutics is a precision neuroscience biotechnology company founded in 2020 and based in San Francisco, California, developing biomarker-gated genetic medicines for central nervous system (CNS) diseases with high unmet need. Its Conditionally Activated siRNA (CASi) platform combines proper

minimal 14.3 / 100 0 APIs View provider profile →

Company Biotech Biotechnology Pharmaceuticals Genetic Medicine RNAi

Switch Therapeutics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.